EUS-guided Radiofrequency Ablation of locally advanced Pancreatic cancer versus standard treatment (ERAP)
Completed
- Conditions
- For unresectable solid pancreatic lesionspancreatic cancer
- Registration Number
- TCTR20180706001
- Lead Sponsor
- Faculty of Medicine King Chulalongkorn Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
1. Malignant Pancreatic Mass
2. Size of Mass is not more than 50mm
3. Concomitant chemotherapy wtihin 4 weeks
4. Expected survival time longer than 3 months
Exclusion Criteria
1. Undergoing radiotherapy
2. ECOG score of more than 2
3. Pregnancy
4. On active heparin or anticoagulant therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method delta of tumor diameter before and after treatment in patients receiving EUS RFA plus CMT versus CMT alone 3 months millimeter
- Secondary Outcome Measures
Name Time Method Tumor necrosis 3 months Necrosis of tumor demonstrated by radiological examination